Literature DB >> 6547954

Phospholipids as acyl donors to membrane proteins of Mycoplasma capricolum.

C E Dahl, J S Dahl.   

Abstract

Mycoplasma capricolum, a procaryotic sterol and fatty acid auxotroph, contains a large number of membrane proteins covalently modified by both saturated and unsaturated fatty acids (Dahl, C.E., Dahl, J.S., and Bloch, K. (1983) J. Biol. Chem. 258, 11814-11818). Pulse-chase experiments show that the radioactivity in the fatty acid moieties of the acyl proteins increases rather than decreases during a 4.5-h incubation period suggesting that a large intracellular pool of metabolites such as phospholipid serves as the donor for protein acylation. We find that cells incubated for 4 h in a growth medium containing [3H]palmitate-labeled phosphatidylglycerol or 2-[3H]palmitoyl dipalmitoylphosphatidylcholine show the same labeling pattern as cells incubated for 4 h in a complete growth medium with [3H]palmitate. Exogenously added phospholipids are not hydrolyzed to free fatty acid during the labeling period. Acylation of proteins is inhibited in cells treated with chloramphenicol showing that there is no pool of proacyl protein in the cell. Labeling of membrane proteins also occurs with [3H]glycerol. Glycerol is incorporated primarily into the same proteins as oleate suggesting that acylation by unsaturated fatty acid may involve a protein bound diglyceride moiety. Palmitate, on the other hand, appears to bind to other sites along the polypeptide chain in addition to the diglyceride moiety.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6547954

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Association of lipids with integral membrane surface proteins of Mycoplasma hyorhinis.

Authors:  T M Bricker; M J Boyer; J Keith; R Watson-McKown; K S Wise
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

2.  Topology and acylation of spiralin.

Authors:  H Wróblewski; S Nyström; A Blanchard; A Wieslander
Journal:  J Bacteriol       Date:  1989-09       Impact factor: 3.490

3.  Lipid-modified surface protein antigens expressing size variation within the species Mycoplasma hyorhinis.

Authors:  M J Boyer; K S Wise
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

4.  Distinctive repertoire of contingency genes conferring mutation- based phase variation and combinatorial expression of surface lipoproteins in Mycoplasma capricolum subsp. capricolum of the Mycoplasma mycoides phylogenetic cluster.

Authors:  Kim S Wise; Mark F Foecking; Kerstin Röske; Young Jin Lee; Young Moo Lee; Anup Madan; Michael J Calcutt
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

5.  Major membrane surface proteins of Mycoplasma hyopneumoniae selectively modified by covalently bound lipid.

Authors:  K S Wise; M F Kim
Journal:  J Bacteriol       Date:  1987-12       Impact factor: 3.490

6.  Subunit structure of the variable V-1 antigen of Mycoplasma pulmonis.

Authors:  H L Watson; K Dybvig; D K Blalock; G H Cassell
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

7.  Acylated proteins in Acholeplasma laidlawii.

Authors:  C E Dahl; N C Sacktor; J S Dahl
Journal:  J Bacteriol       Date:  1985-04       Impact factor: 3.490

8.  Spiralin polymorphism in strains of Spiroplasma citri is not due to differences in posttranslational palmitoylation.

Authors:  X Foissac; C Saillard; J Gandar; L Zreik; J M Bové
Journal:  J Bacteriol       Date:  1996-05       Impact factor: 3.490

9.  Triton X-114 phase fractionation of an integral membrane surface protein mediating monoclonal antibody killing of Mycoplasma hyorhinis.

Authors:  H C Riethman; M J Boyer; K S Wise
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

10.  A glycosylphosphatidylinositol protein anchor from procyclic stage Trypanosoma brucei: lipid structure and biosynthesis.

Authors:  M C Field; A K Menon; G A Cross
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.